http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013237482-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_905ec7708b902bbd132720422ffcbde0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b0c9cbbea1ba6b8eae0ff00e6aeceb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_876b4b58efbaf3319ed4cfa448a36f44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_257d88b2dd397fee7fc2c1203cfc585e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b534e26c051e68f05fe084879ec53210
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
filingDate 2012-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b4fa6498f159259f231478e6555d96a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2796cdce1bd1df351e605aa60eed4191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78d7e276360776dafb2444e01bf879c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b4e8ed6b2b2710787a59a5939d9f303
publicationDate 2013-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2013237482-A1
titleOfInvention Medicament for therapeutic treatment and/or improvement of sepsis
abstract A medicament for therapeutic treatment and/or improvement of sepsis in a patient with severe sepsis accompanied with one or more organ dysfunctions, wherein a value of International Normalized Ratio (INR) of a plasma specimen obtained from said patient is more than 1.4, which comprises thrombomodulin as an active ingredient.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497795-B2
priorityDate 2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14017587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID349960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16051955

Total number of triples: 56.